Cargando…
Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis
BACKGROUND: Endostar is a new endogenous angiogenic inhibitor with implicated anti-tumor activity. This study was to investigate whether thoracic perfusion of Endostar could be used to control malignant pleural effusions (MPE). METHODS: We searched the databases of MEDLINE, Web of Science, EMBASE, G...
Autores principales: | Biaoxue, Rong, Xiguang, Cai, Hua, Liu, Wenlong, Gao, Shuanying, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109813/ https://www.ncbi.nlm.nih.gov/pubmed/27842514 http://dx.doi.org/10.1186/s12885-016-2935-4 |
Ejemplares similares
-
Thoracic perfusion of matrine as an adjuvant treatment improves the control of the malignant pleural effusions
por: Biaoxue, Rong, et al.
Publicado: (2015) -
Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion
por: Biaoxue, Rong, et al.
Publicado: (2016) -
Recombinant Human Endostatin Endostar Suppresses Angiogenesis and Lymphangiogenesis of Malignant Pleural Effusion in Mice
por: Ma, Xingqun, et al.
Publicado: (2012) -
Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer
por: Biaoxue, Rong, et al.
Publicado: (2012) -
Differential diagnostic CYFRA 21-1 level for benign and malignant pleural effusions: a meta-analysis in the Chinese population
por: Biaoxue, Rong, et al.
Publicado: (2012)